Nayyereh Aminisani1, Hosseinali Nikbakht2, Mohammad Asghari Jafarabadi3, Seyed Morteza Shamshirgaran4. 1. Epidemiology and Statistics Department, Faculty of Health Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. 2. Social Determinants of Health Research Centre, Babol University of Medical Sciences and Epidemiology Department, Faculty of Health Sciences, Shiraz University of Medical Sciences, Iran. 3. Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. 4. Epidemiology and Statistics Department, Faculty of Health Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;; Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
BACKGROUND: The aim of this study was to examine the relationship between psychological distress and quality of life (QOL) dimensions in colorectal cancer (CRC) patients. METHODS: This cross-sectional study was conducted in the North of Iran. A total of 157 CRC survivors were selected from the registry database and included in this study. Psychological distress was measured using the Hospital Anxiety and Depression Scale (HADS) and QOL was estimated using the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire C30 (EORTC QLQ C-30). The association between the patients' emotional functioning (EF) score on EORTC QLQ-C30 and their HADS scores was analysed through multiple linear regression. RESULTS: In statistical terms, there were significantly negative relationships between EF and HADS-A (anxiety), and between HADS-D (depression) and HADS-T (total score). However, compared with HADS-A, the correlation between HADS-D and other QOL dimensions was significantly higher. By the same token, depression rather than anxiety was more strongly associated with reduced QOL. CONCLUSIONS: The EF dimension of the EORTC QLQ-C30 predominantly assesses anxiety; however, depression has a stronger impact on the global QOL of patients than anxiety. Therefore, the use of an additional instrument is recommended for the assessment of depression in outpatients with CRC.
BACKGROUND: The aim of this study was to examine the relationship between psychological distress and quality of life (QOL) dimensions in colorectal cancer (CRC) patients. METHODS: This cross-sectional study was conducted in the North of Iran. A total of 157 CRC survivors were selected from the registry database and included in this study. Psychological distress was measured using the Hospital Anxiety and Depression Scale (HADS) and QOL was estimated using the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire C30 (EORTC QLQ C-30). The association between the patients' emotional functioning (EF) score on EORTC QLQ-C30 and their HADS scores was analysed through multiple linear regression. RESULTS: In statistical terms, there were significantly negative relationships between EF and HADS-A (anxiety), and between HADS-D (depression) and HADS-T (total score). However, compared with HADS-A, the correlation between HADS-D and other QOL dimensions was significantly higher. By the same token, depression rather than anxiety was more strongly associated with reduced QOL. CONCLUSIONS: The EF dimension of the EORTC QLQ-C30 predominantly assesses anxiety; however, depression has a stronger impact on the global QOL of patients than anxiety. Therefore, the use of an additional instrument is recommended for the assessment of depression in outpatients with CRC.
Entities:
Keywords:
Anxiety; EORTC QLQ-C30; Hospital Anxiety and Depression Scale (HADS); colorectal cancer (CRC); depression; quality of life (QOL)
Authors: A Montazeri; I Harirchi; M Vahdani; F Khaleghi; S Jarvandi; M Ebrahimi; M Haji-Mahmoodi Journal: Support Care Cancer Date: 1999-11 Impact factor: 3.603
Authors: Sandip M Prasad; Scott E Eggener; Stuart R Lipsitz; Michael R Irwin; Patricia A Ganz; Jim C Hu Journal: J Clin Oncol Date: 2014-07-07 Impact factor: 44.544
Authors: Maike G Sweegers; Laurien M Buffart; Wouke M van Veldhuizen; Edwin Geleijn; Henk M W Verheul; Johannes Brug; Mai J M Chinapaw; Teatske M Altenburg Journal: Oncologist Date: 2018-11-13
Authors: Veena Shankaran; Joseph M Unger; Amy K Darke; Jennifer Marie Suga; James L Wade; Peter J Kourlas; Sreenivasa R Chandana; Mark A O'Rourke; Suma Satti; Diane Liggett; Dawn L Hershman; Scott D Ramsey Journal: J Natl Cancer Inst Date: 2022-03-08 Impact factor: 13.506
Authors: Hyrum S Eddington; Megan McLeod; Amber W Trickey; Nicolas Barreto; Katherine Maturen; Arden M Morris Journal: Cancer Med Date: 2021-05-01 Impact factor: 4.452
Authors: Louis Jacob; Guillermo F López-Sánchez; Lin Yang; Josep Maria Haro; Jae Il Shin; Nicola Veronese; Pinar Soysal; Trish Gorely; Ai Koyanagi; Lee Smith Journal: Eye (Lond) Date: 2020-05-13 Impact factor: 3.775